Ertapenem (disodium)

Ertapenem (MK-0826) disodium is a broad spectrum and long acting β-lactam antibiotic. Ertapenem disodium has a broad-spectrum anti-anaerobic activity against a variety of anaerobes with a mode MIC of 0.12 μg/mL. Ertapenem disodium can be used for the research of severe infections caused by bacteria in the skin, lungs, stomach, pelvis, and urinary tract[1][2].

Product Specifications

CAS Number

[153832-38-3]

Product Name Alternative

MK-0826 (disodium)

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/ertapenem-disodium.html

Purity

98.21

Solubility

H2O : ≥ 100 mg/mL

Smiles

O=C(C(N12)=C(S[C@@H]3CN[C@H](C(NC4=CC=CC(C(O[Na])=O)=C4)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O[Na]

Molecular Formula

C22H23N3Na2O7S

Molecular Weight

519.48

Precautions

H315, H319, H335

References & Citations

[1]Kenneth E Aldridge. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes. Diagn Microbiol Infect Dis. 2002 Oct;44 (2) :181-6. |[2]C J Gill, et al. In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345) . Antimicrob Agents Chemother. 1998 Aug;42 (8) :1996-2001.